Frieri, G.; Valvano, M.; Frassino, S.; Faenza, S.; Cesaro, N.; Amicucci, G.; Manetta, R.; Viscido, A.; Latella, G.
Prophylactic Treatment with Vedolizumab in the Prevention of Postoperative Recurrence (POR) in High-Risk Crohn’s Patients. J. Clin. Med. 2023, 12, 3130.
https://doi.org/10.3390/jcm12093130
AMA Style
Frieri G, Valvano M, Frassino S, Faenza S, Cesaro N, Amicucci G, Manetta R, Viscido A, Latella G.
Prophylactic Treatment with Vedolizumab in the Prevention of Postoperative Recurrence (POR) in High-Risk Crohn’s Patients. Journal of Clinical Medicine. 2023; 12(9):3130.
https://doi.org/10.3390/jcm12093130
Chicago/Turabian Style
Frieri, Giuseppe, Marco Valvano, Sara Frassino, Susanna Faenza, Nicola Cesaro, Gianfranco Amicucci, Rosa Manetta, Angelo Viscido, and Giovanni Latella.
2023. "Prophylactic Treatment with Vedolizumab in the Prevention of Postoperative Recurrence (POR) in High-Risk Crohn’s Patients" Journal of Clinical Medicine 12, no. 9: 3130.
https://doi.org/10.3390/jcm12093130
APA Style
Frieri, G., Valvano, M., Frassino, S., Faenza, S., Cesaro, N., Amicucci, G., Manetta, R., Viscido, A., & Latella, G.
(2023). Prophylactic Treatment with Vedolizumab in the Prevention of Postoperative Recurrence (POR) in High-Risk Crohn’s Patients. Journal of Clinical Medicine, 12(9), 3130.
https://doi.org/10.3390/jcm12093130
